EX-FILING FEES 6 tm2329572d4_ex-filingfees.htm EX-FILING FEES

 

Exhibit 107

 

Calculation of Filing Fee Table

 

Form S-1

(Form Type)

 

Structure Therapeutics Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

   Security
Type		  Security
Class Title(1)		  Fee
Calculation
Rule		  Amount
Registered(2)		   Proposed
Maximum
Offering
Price Per
Share(4)		   Maximum
Aggregate
Offering
Price		   Fee Rate   Amount of
Registration
Fee		 
Fees to Be Paid  Equity  Ordinary Shares, $0.0001 par value per share  Rule 457(c)   24,019,215(3)   $15.10   $362,690,146.50    0.0001476   $53,533.07 
         Total Offering Amounts   $362,690,146.50        $53,533.07 
         Total Fees Previously Paid                
         Total Fee Offsets                
         Net Fee Due             $53,533.07 

 

(1)The ordinary shares (“Ordinary Shares”), $0.0001 par value per share, of Structure Therapeutics Inc. (the “Registrant”) are represented by American Depositary Shares (“ADSs”), each representing three Ordinary Shares.
(2)Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the securities being registered hereunder also include such indeterminate number of securities as may be issuable with respect to the securities being registered hereunder as a result of stock splits, stock dividends or similar transactions.
(3)This registration statement registers an aggregate of 24,019,215 of Ordinary Shares (represented by 8,006,405 ADSs) consisting of (i) an aggregate of 21,617,295 Ordinary Shares (represented by 7,205,765 ADSs) and (ii) 2,401,920 Ordinary Shares issuable upon conversion of non-voting ordinary shares (represented by 800,640 ADSs), all of which were acquired by the selling shareholders in a private placement.
(4)Estimated in accordance with Rule 457(c) of the Securities Act solely for purposes of calculating the registration fee, and is based upon the price of $15.10 per Ordinary Share (or the equivalent of $45.31 per ADS), which was the average of the high and low prices of the Registrant’s ADSs as reported on the Nasdaq Global Market on November 16, 2023, which date is within five business days prior to the filing of this registration statement.